Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females

Summary

\- Objectives: Primary objective\_To evaluate the safety and tolerability after single oral administration of the investigational product (IP), J2H-1702 in healthy female subjects. Secondary objective\_To evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) characteristics after single oral administration of the IP, J2H-1702 in healthy female subjects.

Timeline

Start

2023-01-02

Primary completion

2023-02-17

Completion

2023-02-17

Drugs

Indications